NCT05100511

Brief Summary

The purpose of this study is to investigate the usability of fundus image-guided focal electroretinography device with healthy subjects and with macular edema and macular degeneration patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

November 4, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2022

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2021

Enrollment Period

10 months

First QC Date

October 6, 2021

Last Update Submit

November 7, 2022

Conditions

Keywords

ElectroretinographyERG

Outcome Measures

Primary Outcomes (2)

  • Signal-to-noise ratio of focal electroretinography signal

    Signal-to-noise ratio of the focal ERG signals with different ERG electrodes.

    Through study completion, an average of 1 year

  • Focal ERG from symptomatic retinal area

    Explore the device feasibility in recording focal ERG signal from areas with macular edema or macular degeneration.

    Through study completion, an average of 1 year

Secondary Outcomes (1)

  • Patient comfort and usability of different ERG electrodes in focal ERG.

    Through study completion, an average of 1 year

Study Arms (2)

Phase I, healthy subjects

EXPERIMENTAL

General usability of the device is tested with healthy patients. Different commercial electroretinography electrodes are tested to investigate the patient comfort, usability and signal-to-noise ratio when recording fundus image-guided focal electroretinography with the investigational device. Most suitable electrode is selected to phase II.

Device: ERG electrode tests for fundus image-guided focal ERG

Phase II, patients with macular edema or macular degeneration

EXPERIMENTAL

The usability of the device is tested with patients suffering either from macular edema or macular degeneration. Fundus image-guided focal electroretinography is recorded with the electrode chosen in phase I from two different retinal areas: from an area with macular edema or signs of macular degeneration and from a healthy area (area without macular edema or signs of macular degeneration).

Device: Fundus image-guided focal ERG

Interventions

Investigate the patient comfort, usability and signal-to-noise ratio of different commercial CE marked ERG electrodes.

Phase I, healthy subjects

Record focal ERG from a healthy retinal area and from an area with visible symptoms.

Phase II, patients with macular edema or macular degeneration

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers with no signs of macular edema or macular degeneration (phase I)
  • Patients with either macular edema or macular degeneration (phase II)
  • Able to give informed consent

You may not qualify if:

  • Epileptic patients
  • Vulnerable population: pregnant and breastfeeding women, underage, prisoners, persons with physical handicaps or mental disabilities, and disadvantaged persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helsinki University Hospital, Retinal Outpatient Clinic

Helsinki, Uusimaa, 00280, Finland

Location

MeSH Terms

Conditions

Macular EdemaMacular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Officials

  • Joni Turunen, MD

    Helsinki University Central Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: The usability of the investigational device is examined first with 10 healthy subjects and afterwards with total of 10 patients suffering either from macular edema or macular degeneration.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2021

First Posted

October 29, 2021

Study Start

November 4, 2021

Primary Completion

August 25, 2022

Study Completion

August 25, 2022

Last Updated

November 8, 2022

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations